Sai Life Sciences Limited (BOM:544306)

Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 12, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	151,258	158,581	-	-	-	-
Enterprise Value	150,143	166,413	-	-	-	-
Last Close Price	725.55	762.10	-	-	-	-
PE Ratio	88.91	93.21	-	-	-	-
PS Ratio	8.74	9.16	-	-	-	-
PB Ratio	7.11	7.45	-	-	-	-
P/TBV Ratio	7.14	7.49	-	-	-	-
P/OCF Ratio	48.16	50.50	-	-	-	-
EV/Sales Ratio	8.67	9.61	-	-	-	-
EV/EBITDA Ratio	33.94	37.61	-	-	-	-
EV/EBIT Ratio	49.41	54.77	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.80	0.80	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Asset Turnover	0.64	0.64	0.66	0.56	0.44	-
Inventory Turnover	4.51	4.51	4.27	3.50	3.04	-
Quick Ratio	1.12	1.12	1.05	0.93	0.99	1.05
Current Ratio	2.05	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	10.96%	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	6.99%	6.99%	4.83%	1.90%	0.98%	-
Return on Capital (ROIC)	8.66%	8.66%	5.78%	2.25%	1.15%	-
Return on Capital Employed (ROCE)	12.50%	12.50%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.12%	1.07%	-	-	-	-
FCF Yield	-0.37%	-0.35%	-	-	-	-
Buyback Yield / Dilution	-8.04%	-8.04%	-0.27%	-0.46%	-5.32%	-

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.